443 related articles for article (PubMed ID: 30027226)
21. Should "indeterminate" diagnoses be used for thyroid fine-needle aspirates of nodules smaller than 1 cm?
Renshaw AA; Gould EW
Arch Pathol Lab Med; 2013 Nov; 137(11):1627-9. PubMed ID: 24168500
[TBL] [Abstract][Full Text] [Related]
22. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
23. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic lobectomy is not routinely required to exclude malignancy in thyroid nodules greater than four centimetres.
Raj MD; Grodski S; Woodruff S; Yeung M; Paul E; Serpell JW
ANZ J Surg; 2012; 82(1-2):73-7. PubMed ID: 22507501
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy for thyroid nodules three centimeters or larger in size.
Ucler R; Usluogulları CA; Tam AA; Ozdemir D; Balkan F; Yalcın S; Kıyak G; Ersoy PE; Guler G; Ersoy R; Cakır B
Diagn Cytopathol; 2015 Aug; 43(8):622-8. PubMed ID: 25914194
[TBL] [Abstract][Full Text] [Related]
26. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
[TBL] [Abstract][Full Text] [Related]
27. Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data.
Eilers SG; LaPolice P; Mukunyadzi P; Kapur U; Wendel Spiczka A; Shah A; Saleh H; Adeniran A; Nunez A; Balachandran I; Clark JJ; Lemon L
Cancer Cytopathol; 2014 Oct; 122(10):745-50. PubMed ID: 24913410
[TBL] [Abstract][Full Text] [Related]
28. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
29. Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations.
Hodax JK; Bowerman K; Quintos JB
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):895-901. PubMed ID: 31271555
[TBL] [Abstract][Full Text] [Related]
30. Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology.
Rago T; Scutari M; Loiacono V; Tonacchera M; Scuotri G; Romani R; Proietti A; Piaggi P; Elisei R; Basolo F; Latrofa F; Vitti P
Thyroid; 2018 Oct; 28(10):1318-1324. PubMed ID: 30132418
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
[TBL] [Abstract][Full Text] [Related]
32. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
33. Thyroid Nodule Size as a Predictor of Malignancy in Follicular and Hurthle Neoplasms.
Boonrod A; Akkus Z; Castro MR; Zeinodini A; Philbrick K; Stan M; Erickson D; Erickson B
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2597-2602. PubMed ID: 34452575
[TBL] [Abstract][Full Text] [Related]
34. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.
Petric R; Besic H; Besic N
World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
[TBL] [Abstract][Full Text] [Related]
37. Thyroid nodule size and prediction of cancer.
Kamran SC; Marqusee E; Kim MI; Frates MC; Ritner J; Peters H; Benson CB; Doubilet PM; Cibas ES; Barletta J; Cho N; Gawande A; Ruan D; Moore FD; Pou K; Larsen PR; Alexander EK
J Clin Endocrinol Metab; 2013 Feb; 98(2):564-70. PubMed ID: 23275525
[TBL] [Abstract][Full Text] [Related]
38. False negative cytology in large thyroid nodules.
Giles WH; Maclellan RA; Gawande AA; Ruan DT; Alexander EK; Moore FD; Cho NL
Ann Surg Oncol; 2015 Jan; 22(1):152-7. PubMed ID: 25074665
[TBL] [Abstract][Full Text] [Related]
39. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
40. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
